Michael Schaff, Chair of the Corporate and Health Law groups and Co-Chair of the Cannabis Law group, was selected by the New Jersey State Bar Association as Co-Chair of the NJSBA Cannabis Law Committee. NJSBA supports 18,000 members by fostering professionalism, advancing personal development and encouraging participation.
At Wilentz, Mr. Schaff’s practice spans over 30 years. He represents physicians, physician groups, hospitals, CINs, MSOs, ASCs, facilities and businesses dealing with them in all areas of healthcare law, leading a team of top ranked healthcare lawyers who regularly advise on legal issues facing the health law and cannabis industry; as well as regulatory and operational issues involved in building, investing in, and growing successful healthcare and cannabis businesses.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.